Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study
Open Access
- 1 October 2018
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 98 (9), 829-834
- https://doi.org/10.2340/00015555-2989
Abstract
Safety data for secukinumab in patients with psoriasis and viral hepatitis are lacking. The aim of t...Keywords
This publication has 40 references indexed in Scilit:
- Analysis of CD137L and IL-17 Expression in Tumor Tissue as Prognostic Indicators for GliblastomaInternational Journal of Biological Sciences, 2013
- Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative HepatectomyPLOS ONE, 2012
- Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFα agents: A retrospective analysis of 49 casesClinical Rheumatology, 2012
- Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted TherapyMedicine, 2011
- Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic reviewRheumatology, 2011
- Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of actionClinical Rheumatology, 2010
- Translational Mini-Review Series on Th17 Cells: Function and regulation of human T helper 17 cells in health and diseaseClinical and Experimental Immunology, 2009
- Reactivation of hepatitis BJournal of Hepatology, 2009
- Interleukin‐17 in host defence against bacterial, mycobacterial and fungal pathogensImmunology, 2009
- Viral load as a predictor of progression of chronic hepatitis C?Journal of Hepatology, 2005